Dr. John Cijiang He is a Professor of Medicine and Pharmacological Sciences at Icahn School of Medicine at Mount Sinai. He holds the title of Irene and Dr. Arthur M. Fishberg endowed chair of Nephrology. He is the division chief of Nephrology at Mount Sinai Health System. He has been practicing nephrology for more than 20 years. He also has more than 20 years’ research experience. His research interest has been in the fields of kidney cell biology and the mechanisms of chronic kidney disease including kidney fibrosis. His lab uses systems biology approach to identify potential new biomarkers and drug targets for chronic kidney diseases. As one of these examples, his lab used systems biology approach to identify HIPK2 as a key driver for kidney fibrosis and this work leads to the discovery of HIPK2 inhibitors as anti-fibrosis drugs for chronic kidney disease. He has published more than 270 peer-reviewed papers in these fields